lilotomab

lilotomab (gatamlo tetulomab, tetulomab anedi anedi kuu vyatiraekamgaa unde murine monoclonal antibody, idhi glycoprotein, idhi parinati chendina maanava bii kanaala uparitalampai vyakteekarinchabadutundi. idhi norwegian radium aasupatrilo utpatti cheyabadindi.
2016 natiki idhi norwegian company nordic nanovector aasaa dwara radeo immunotherapeuticga abhivruddhi cheyabadutondi, dheenilo lilotomab beata radiation-emitting isotope lutasium-177 thoo satetroxeton anae linker dwara samyogam cheyabadutundi, idhi dota yokka utpannam. eee sammelanaanni sammelanaanni ledhaa lutasium (177luu) lilotomab satetroxeton (vaanijya paeru "beetalutin") anie pilustaaru. 2016 natiki, naan-hodgkin lymphoma unnavaarilo okatinnara dasha clinical trial jarugutondi.

